Filing Details

Accession Number:
0001578563-24-000441
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-14 17:21:55
Reporting Period:
2024-11-12
Accepted Time:
2024-11-14 17:21:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534120 Avalo Therapeutics Inc. AVTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492647 Sherie June Almenoff C/O Avalo Therapeutics, Inc.
540 Gaither Road, Suite 400
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-12 500 $12.50 500 No 4 P Indirect By Meadowlark Management, LLC
Common Stock Acquisiton 2024-11-13 500 $13.00 1,000 No 4 P Indirect By Meadowlark Management, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Meadowlark Management, LLC
No 4 P Indirect By Meadowlark Management, LLC
Footnotes
  1. This transaction was executed in multiple trades ranging from $12.00 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.